PAPER Ashe KH
SEARCH RESULTS
330712 RESULTS
PAPER Hyman BT
The natural history of Alzheimer disease dissected through multiphoton imaging of transgenic mice.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):206-9. PubMed: 17132963PAPER Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, Galasko D, Graff-Radford N, Peskind ER, Beekly D, Ramos EM, Kukull WA
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):210-6. PubMed: 17132964PAPER Apostolova LG, Lu PH, Rogers S, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM
3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):224-31. PubMed: 17132966PAPER Sano M, Egelko S, Jin S, Cummings J, Clark CM, Pawluczyk S, Thomas RJ, Schittini M, Thal LJ,
Spanish instrument protocol: new treatment efficacy instruments for Spanish-speaking patients in Alzheimer disease clinical trials.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):232-41. PubMed: 17132967PAPER Kapaki E, Paraskevas GP, Mantzou E, Papapostolou A, Alevizaki M, Vassilopoulos D
Thyroid function in patients with Alzheimer disease: implications on response to anticholinesterase treatment.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):242-7. PubMed: 17132968PAPER Blesa R, Aguilar M, Casanova JP, Boada M, Martínez S, Alom J, de la Hoz CH, Sancho J, Fernández O, Gil-Neciga E, Massó JF
Relationship between the efficacy of rivastigmine and apolipoprotein E (epsilon4) in patients with mild to moderately severe Alzheimer disease.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):248-54. PubMed: 17132969PAPER Schmitt FA, van Dyck CH, Wichems CH, Olin JT,
Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):255-62. PubMed: 17132970PAPER Feldman HH, Schmitt FA, Olin JT,
Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):263-8. PubMed: 17132971PAPER Farina E, Mantovani F, Fioravanti R, Rotella G, Villanelli F, Imbornone E, Olivotto F, Tincani M, Alberoni M, Petrone E, Nemni R, Postiglione A
Efficacy of recreational and occupational activities associated to psychologic support in mild to moderate Alzheimer disease: a multicenter controlled study.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):275-82. PubMed: 17132973PAPER Klünemann HH, Fronhöfer W, Werner-Füchtenbusch D, Grasbon-Frodl E, Kloiber S, Wurster HW, St George-Hyslop PH, Rogaeva E
Characterization of the kindred of Alois Alzheimer's patient with plaque-only dementia.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):291-4. PubMed: 17132975PAPER Molnar FJ, Patel A, Marshall SC, Man-Son-Hing M, Wilson KG
Systematic review of the optimal frequency of follow-up in persons with mild dementia who continue to drive.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):295-7. PubMed: 17132976PAPER Craft S
Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):298-301. PubMed: 17132977PAPER Galvin JE
Cognitive change in Parkinson disease.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):302-10. PubMed: 17132978PAPER Lipinski B, Sajdel-Sulkowska EM
New insight into Alzheimer disease: demonstration of fibrin(ogen)-serum albumin insoluble deposits in brain tissue.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):323-6. PubMed: 17132984Current Filters
- Date Range : All x